These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15225685)

  • 1. Estrogen receptor ligands. Part 7: Dihydrobenzoxathiin SERAMs with bicyclic amine side chains.
    Blizzard TA; DiNinno F; Morgan JD; Chen HY; Wu JY; Gude C; Kim S; Chan W; Birzin ET; Tien Yang Y; Pai LY; Zhang Z; Hayes EC; DaSilva CA; Tang W; Rohrer SP; Schaeffer JM; Hammond ML
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3861-4. PubMed ID: 15225685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor ligands. Part 8: Dihydrobenzoxathiin SERAMs with heteroatom-substituted side chains.
    Blizzard TA; DiNinno F; Morgan JD; Wu JY; Chen HY; Kim S; Chan W; Birzin ET; Yang YT; Pai LY; Zhang Z; Hayes EC; DaSilva CA; Tang W; Rohrer SP; Schaeffer JM; Hammond ML
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3865-8. PubMed ID: 15225686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor ligands. Part 9: Dihydrobenzoxathiin SERAMs with alkyl substituted pyrrolidine side chains and linkers.
    Blizzard TA; Dininno F; Morgan JD; Chen HY; Wu JY; Kim S; Chan W; Birzin ET; Yang YT; Pai LY; Fitzgerald PM; Sharma N; Li Y; Zhang Z; Hayes EC; Dasilva CA; Tang W; Rohrer SP; Schaeffer JM; Hammond ML
    Bioorg Med Chem Lett; 2005 Jan; 15(1):107-13. PubMed ID: 15582421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor ligands. Part 13: Dihydrobenzoxathiin SERAMs with an optimized antagonist side chain.
    Blizzard TA; DiNinno F; Chen HY; Kim S; Wu JY; Chan W; Birzin ET; Yang YT; Pai LY; Hayes EC; DaSilva CA; Rohrer SP; Schaeffer JM; Hammond ML
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3912-6. PubMed ID: 15993065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor ligands. Part 6: Synthesis and binding affinity of dihydrobenzodithiins.
    Tan Q; Birzin ET; Chan W; Yang YT; Pai LY; Hayes EC; DaSilva CA; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3753-5. PubMed ID: 15203156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor ligands. Part 4: The SAR of the syn-dihydrobenzoxathiin SERAMs.
    Kim S; Wu J; Chen HY; Birzin ET; Chan W; Yang YT; Colwell L; Li S; Dahllund J; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2741-5. PubMed ID: 15125925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor ligands. II. Discovery of benzoxathiins as potent, selective estrogen receptor alpha modulators.
    Kim S; Wu JY; Birzin ET; Frisch K; Chan W; Pai LY; Yang YT; Mosley RT; Fitzgerald PM; Sharma N; Dahllund J; Thorsell AG; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
    J Med Chem; 2004 Apr; 47(9):2171-5. PubMed ID: 15084115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bridged bicyclic cores containing a 1,1-diarylethylene motif are high-affinity subtype-selective ligands for the estrogen receptor.
    Muthyala RS; Sheng S; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2003 Apr; 46(9):1589-602. PubMed ID: 12699377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor ligands. Part 3: The SAR of dihydrobenzoxathiin SERMs.
    Chen HY; Kim S; Wu JY; Birzin ET; Chan W; Yang YT; Dahllund J; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
    Bioorg Med Chem Lett; 2004 May; 14(10):2551-4. PubMed ID: 15109649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor ligands. Part 10: Chromanes: old scaffolds for new SERAMs.
    Tan Q; Blizzard TA; Morgan JD; Birzin ET; Chan W; Yang YT; Pai LY; Hayes EC; DaSilva CA; Warrier S; Yudkovitz J; Wilkinson HA; Sharma N; Fitzgerald PM; Li S; Colwell L; Fisher JE; Adamski S; Reszka AA; Kimmel D; DiNinno F; Rohrer SP; Freedman LP; Schaeffer JM; Hammond ML
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1675-81. PubMed ID: 15745820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of the bicyclo[3.3.1]nonane system as a template for the development of new ligands for the estrogen receptor.
    Muthyala RS; Carlson KE; Katzenellenbogen JA
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4485-8. PubMed ID: 14643352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor ligands. Part 14: application of novel antagonist side chains to existing platforms.
    Blizzard TA; Morgan JD; Chan W; Birzin ET; Pai LY; Hayes EC; DaSilva CA; Mosley RT; Yang YT; Rohrer SP; Dininno F; Hammond ML
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5124-8. PubMed ID: 16203138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomedicine. Defining the "S" in SERMs.
    Katzenellenbogen BS; Katzenellenbogen JA
    Science; 2002 Mar; 295(5564):2380-1. PubMed ID: 11923515
    [No Abstract]   [Full Text] [Related]  

  • 14. Discovery of novel SERMs with a ferrocenyl entity based on the oxabicyclo[2.2.1]heptene scaffold and evaluation of their antiproliferative effects in breast cancer cells.
    Zheng Y; Wang C; Li C; Qiao J; Zhang F; Huang M; Ren W; Dong C; Huang J; Zhou HB
    Org Biomol Chem; 2012 Dec; 10(48):9689-99. PubMed ID: 23149805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrahydroquinoline-based selective estrogen receptor modulators (SERMs).
    Wallace OB; Lauwers KS; Jones SA; Dodge JA
    Bioorg Med Chem Lett; 2003 Jun; 13(11):1907-10. PubMed ID: 12749895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships and sub-type selectivity in an oxabicyclic estrogen receptor alpha/beta agonist scaffold.
    Hamann LG; Meyer JH; Ruppar DA; Marschke KB; Lopez FJ; Allegretto EA; Karanewsky DS
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1463-6. PubMed ID: 15713407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor ligands. Part 5: The SAR of dihydrobenzoxathiins containing modified basic side chains.
    Tan Q; Birzin ET; Chan W; Tien Yang Y; Pai LY; Hayes EC; DaSilva CA; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3747-51. PubMed ID: 15203155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and estrogen receptor binding affinities of 7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-ones containing a basic side chain.
    Kim YW; Mobley JA; Brueggemeier RW
    Bioorg Med Chem Lett; 2003 Apr; 13(8):1475-8. PubMed ID: 12668015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and structure-activity analysis of selective estrogen receptor modulators via similarity-based virtual screening.
    Shen J; Jiang J; Kuang G; Tan C; Liu G; Huang J; Tang Y
    Eur J Med Chem; 2012 Aug; 54():188-96. PubMed ID: 22647217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional models of non-steroidal ligands: a comparative molecular field analysis.
    Menezes IR; Leitão A; Montanari CA
    Steroids; 2006 Jun; 71(6):417-28. PubMed ID: 16481019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.